Log in

Relevant bibliographies by topics / Chronic ischemic heart disease / Journal articles

To see the other types of publications on this topic, follow the link: Chronic ischemic heart disease.

Journal articles on the topic 'Chronic ischemic heart disease'

Author: Grafiati

Published: 28 May 2022

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Chronic ischemic heart disease.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Tsiatis, Anastasios A., and Michael A. Gent. "Chronic ischemic heart disease." American Heart Journal 139, no. 4 (2000): 0182–88. http://dx.doi.org/10.1067/mhj.2000.104845.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Gent, Michael, and Robert M. Califf. "Chronic ischemic heart disease." American Heart Journal 139, no. 4 (2000): S182—S188. http://dx.doi.org/10.1016/s0002-8703(00)90069-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Keenan, Andrew M. "Atlas of Heart Diseases: Chronic Ischemic Heart Disease." CLINICAL NUCLEAR MEDICINE 22, no. 9 (1997): 662. http://dx.doi.org/10.1097/00003072-199709000-00030.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Dzhaiani, N. A. "CANDESARTAN IN CARDIOLOGY PRACTICE." Medical Council, no. 7 (December 30, 2017): 12–16. http://dx.doi.org/10.21518/2079-701x-2017-7-12-16.

Full text

Abstract:

The most significant risk factor for the development of cardiovascular diseases such as myocardial infarction, ischemic heart disease, chronic heart failure, is arterial hypertension (AH). [1] AH also contributes to the development of cerebrovascular pathology (ischemic or hemorrhagic stroke, transient ischemic attack) and kidney diseases (chronic kidney disease).

APA, Harvard, Vancouver, ISO, and other styles

5

Karpov, Yu A. "Chronic ischemic heart disease: treatment news." Consilium Medicum 18, no. 1 (2016): 38–44. http://dx.doi.org/10.26442/2075-1753_2016.1.38-44.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Parfrey, Patrick S., and Robert N. Foley. "Ischemic Heart Disease in Chronic Uremia." Blood Purification 14, no. 4 (1996): 321–26. http://dx.doi.org/10.1159/000170280.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Dr., Aijaz Ahmed Dr. Muhammad Nadeem Ahsan Dr. Pooran Mal* Dr. Hamid Nawaz Ali Memon Dr. Samreen and Dr. Sajjad Ali. "ISCHEMIC HEART DISEASE IN PATIENTS OF CHRONIC KIDNEY DISEASE ON MAINTENANCE HEMODIALYSIS." Indo American Journal of Pharmaceutical Sciences 04, no. 11 (2017): 4381–85. https://doi.org/10.5281/zenodo.1064349.

Full text

Abstract:

Objective: To determine the frequency of ischemic heart disease in patients of chronic kidney disease on maintenance hemodialysis Patients and Methods: A total of 160 patients with diagnosis of CKD in department of Nephrology, Liaquat National Hospital Karachi were recruited in this six months cross sectional study. Demographic information was recorded. Then patients were underwent ECG. Reports were assessed and ischemic heart disease was labeled while all the data was collected using the proforma. Results: The mean age of the patients was 55.97±7.27 years. There were 102(63.75%) male a

APA, Harvard, Vancouver, ISO, and other styles

8

Stride, Nis, Steen Larsen, Martin Hey-Mogensen, et al. "Impaired mitochondrial function in chronically ischemic human heart." American Journal of Physiology-Heart and Circulatory Physiology 304, no. 11 (2013): H1407—H1414. http://dx.doi.org/10.1152/ajpheart.00991.2012.

Full text

Abstract:

Chronic ischemic heart disease is associated with myocardial hypoperfusion. The resulting hypoxia potentially inflicts damage upon the mitochondria, leading to a compromised energetic state. Furthermore, ischemic damage may cause excessive production of reactive oxygen species (ROS), producing mitochondrial damage, hereby reinforcing a vicious circle. Ischemic preconditioning has been proven protective in acute ischemia, but the subject of chronic ischemic preconditioning has not been explored in humans. We hypothesized that mitochondrial respiratory capacity would be diminished in chronic isc

APA, Harvard, Vancouver, ISO, and other styles

9

Parfrey, Patrick S., John D. Harnett, and Robert N. Foley. "Heart failure and ischemic heart disease in chronic uremia." Current Opinion in Nephrology and Hypertension 4, no. 2 (1995): 105–10. http://dx.doi.org/10.1097/00041552-199503000-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Bales, Amy C. "Medical management of chronic ischemic heart disease." Postgraduate Medicine 115, no. 2 (2004): 39–46. http://dx.doi.org/10.3810/pgm.2004.02.1439.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Pepine, Carl J., and Wilmer W. Nichols. "The pathophysiology of chronic ischemic heart disease." Clinical Cardiology 30, S1 (2007): I4—I9. http://dx.doi.org/10.1002/clc.20048.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Morrone, Doralisa. "Spasm, inflammation, coronary microcirculation and metabolism: how big is the iceberg under the stenosis." CARDIOLOGIA AMBULATORIALE 30, no. 2 (2022): 9–13. http://dx.doi.org/10.17473/1971-6818-2022-2-2.

Full text

Abstract:

Ischemic heart disease (IHD) is a leading global cause of death and coronary artery disease has long been considered the main determinant of inducible ischemia and symptoms. However, after the performance of hundreds of thousands of percutaneous coronary revascularizations (PCI) worldwide, outcome analysis suggests that the direct relationship between chronic obstructive coronary atherosclerosis and ischemic heart disease (IHD) may represent a too simplified view of IHD; growing evidence has demonstrated the importance of a number of other underlying mechanisms. The purpose of this review is t

APA, Harvard, Vancouver, ISO, and other styles

13

Akramova, E. G. "The features of time characteristics of heart rate variability in chronic obstructive pulmonary disease." Kazan medical journal 93, no. 2 (2012): 172–77. http://dx.doi.org/10.17816/kmj2281.

Full text

Abstract:

Aim. To study the features of time characteristics of heart rate variability during isolated chronic obstructive pulmonary disease, as well as in association with arterial hypertension and ischemic heart disease. Methods. The characteristics of heart rate variability using Holter electrocardiography monitoring, echocardiography and duplex scanning of carotid arteries were studied. The results of investigations of 298 individuals of both sexes aged 37-78 years were included into the analysis, including 79 patients with chronic obstructive pulmonary disease who were divided into three groups. Th

APA, Harvard, Vancouver, ISO, and other styles

14

Akhmedov, A. T., and L. A. Narziev. "PREDICTORS OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE AFTER BYPASS SURGERY." International Journal of Medical Sciences And Clinical Research 03, no. 03 (2023): 68–77. http://dx.doi.org/10.37547/ijmscr/volume03issue03-10.

Full text

Abstract:

The authors studied137 patients with coronary artery disease who underwent coronary artery bypass grafting under cardiopulmonary bypass. At follow-up for 2-5 years, deaths due to cardiac causes were recorded, including cases of sudden death, as well as the development of non-fatal cardiovascular complications.

APA, Harvard, Vancouver, ISO, and other styles

15

Abbas, Eslam, Ahmed Mahdy, and Shady Mansy. "Relentless Angina of a Scarred Heart." Cardiology and Cardiovascular Research 8, no. 4 (2024): 92–95. https://doi.org/10.11648/j.ccr.20240804.11.

Full text

Abstract:

Refractory anginal pain affects nearly 5-10% of stable coronary artery disease patients, and maximizing the anti-ischemic medical therapy is the standard first-line treatment. The presence of a scarred myocardial territory of the epicardial coronary chronic total occlusion (CTO) limits the implementation of other modalities, such as angioplasty and surgical bypass. Accordingly, this subset of patients, who show poor response to medical treatment with the absence of considerable reversible ischemia, bears an additional burden of persistent angina besides the structural and functional complicati

APA, Harvard, Vancouver, ISO, and other styles

16

Bunenkova, G. F., S. P. Salikova, V. B. Grinevich, and E. S. Ivanyuk. "Role of myeloperoxidase in atrial fibrillation and ischemic heart disease." Clinician 16, no. 3 (2023): 18–24. http://dx.doi.org/10.17650/1818-8338-2022-16-3-k664.

Full text

Abstract:

Atrial fibrillation and ischemic heart disease are the key problems in cardiology. Despite of numerous clinical trials and researches underlying molecular biology remains uncertain. Atrial fibrillation and ischemic heart disease are often combined. During ischemic heart disease progression myocardial tissue structure are changing which lead to structural and electrophysiological remodeling and promote atrial fibrillation. It has been shown a crucial role of oxidative stress and chronic systemic inflammation in ischemic heart disease and atrial fibrillation. Myeloperoxidase (MPO) is one of mark

APA, Harvard, Vancouver, ISO, and other styles

17

Burtovaia, E., T. Kantina, and E. Litvinchuk. "Long-Term Mental Disorders in the Accident-Exposed Population of the Southern Urals." Medical Radiology and radiation safety 65, no. 4 (2020): 22–28. http://dx.doi.org/10.12737/1024-6177-2020-65-4-22-28.

Full text

Abstract:

Purpose: To study late mental and behavioral disorders (ICD-10) in individuals who were accidentally exposed in the Southern Urals. Material and methods: The research subjects are the persons who were exposed to radiation as a result of dumping of radioactive waste into the Techa River (1949–1956), who were born before 1953 and lived in the Techa River basin between 1950 and 1960. The study group consists of 425 people, women predominate (72.5 %), people with secondary special education make up 44.5 %, and pensioners amount to 89.4 %. Mean age at examination was 67.3 ± 5.3 years. Informa

APA, Harvard, Vancouver, ISO, and other styles

18

Prikhodko, Viktoriia, and Diana Moreva. "Features of the Course and Treatment of Hypertension in Combination with Chronicis Chemic Heart Disease in Patients with Gastroesophagel Refluxdisease. Role of Proton Pump Inhibitors Test in the Diagnosis and Treatment of Different Forms of GERD." Family Medicine, no. 4 (December 30, 2016): 75–80. http://dx.doi.org/10.30841/2307-5112.4.2016.248527.

Full text

Abstract:

The analysis of epidemiological data shows that the prevalence of GERD in Ukraine is 11.1. Prevalence of GERD increases with the age of respondents, which leads to changes in the structure of clinical disease and dominance of extraesophageal manifestations of disease. The objective: To study features of arterial hypertension (AH) combined with chronic coronary heart disease (CHD) in patients with GERD. Establish a connection presence of gastroesophageal reflux with possible clinical manifestations of coronary heart disease (arrhythmias, ischemic episodes according to the daily ECG monito

APA, Harvard, Vancouver, ISO, and other styles

19

Ellenbogen, Kenneth A. "Reviews and Notes: Cardiology: Chronic Ischemic Heart Disease." Annals of Internal Medicine 125, no. 1 (1996): 80. http://dx.doi.org/10.7326/0003-4819-125-1-199607010-00021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Fox, Kim M., Richard D. Levy, and Arshed A. Quyyumi. "Choice of therapy in chronic ischemic heart disease." American Journal of Cardiology 60, no. 2 (1987): 33–35. http://dx.doi.org/10.1016/0002-9149(87)90497-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Karetnikova, V. N., and A. G. Neyeshpapa. "Successful drug therapy of chronic heart failure in a patient with complex cardiomyopathy and type 2 diabetes mellitus." RMJ, no. 9 (2024): 34–39. https://doi.org/10.32364/2225-2282-2024-9-6.

Full text

Abstract:

Chronic heart failure is an outcome of various cardiac diseases (including ischemic heart disease and hypertension), especially in the absence of adequate therapy for the underlying disease. Type 2 diabetes mellitus not only exacerbates the course of existing heart failure, but also contributes to its development. Patients with a combination of the above mentioned conditions need comprehensive treatment to compensate all the pathological links of diseases with mutual aggravation. Advanced complex therapy for heart failure can significantly improve the subjective and objective status, as well a

APA, Harvard, Vancouver, ISO, and other styles

22

Shih, Hsin-I., Tzu-Yuan Chao, Yi-Ting Huang, et al. "Increased Medical Visits and Mortality among Adults with Cardiovascular Diseases in Severely Affected Areas after Typhoon Morakot." International Journal of Environmental Research and Public Health 17, no. 18 (2020): 6531. http://dx.doi.org/10.3390/ijerph17186531.

Full text

Abstract:

Natural disasters have negative health impacts on chronic diseases in affected populations. Severely affected areas are usually rural areas with limited basic infrastructure and a population have that has limited access to optimal healthcare after a disaster. Patients with cardiovascular diseases are required to maintain quality care, especially after disasters. A population-based case-control study enrolled adults from the National Health Insurance Registry who had ischemic heart disease and cerebrovascular disease histories and lived in the area affected by Typhoon Morakot in 2009. Monthly m

APA, Harvard, Vancouver, ISO, and other styles

23

Padala, Santosh K., Michael P. Lavelle, Mandeep S. Sidhu, et al. "Antianginal Therapy for Stable Ischemic Heart Disease." Journal of Cardiovascular Pharmacology and Therapeutics 22, no. 6 (2017): 499–510. http://dx.doi.org/10.1177/1074248417698224.

Full text

Abstract:

Chronic angina pectoris is associated with considerable morbidity and mortality, especially if treated suboptimally. For many patients, aggressive pharmacologic intervention is necessary in order to alleviate anginal symptoms. The optimal treatment of stable ischemic heart disease (SIHD) should be the prevention of angina and ischemia, with the goal of maximizing both quality and quantity of life. In addition to effective risk factor modification with lifestyle changes, intensive pharmacologic secondary prevention is the therapeutic cornerstone in managing patients with SIHD. Current guideline

APA, Harvard, Vancouver, ISO, and other styles

24

Kaur-Knudsen, Diljit, Stig E. Bojesen, Anne Tybjærg-Hansen, and Børge G. Nordestgaard. "Nicotinic Acetylcholine Receptor Polymorphism, Smoking Behavior, and Tobacco-Related Cancer and Lung and Cardiovascular Diseases: A Cohort Study." Journal of Clinical Oncology 29, no. 21 (2011): 2875–82. http://dx.doi.org/10.1200/jco.2010.32.9870.

Full text

Abstract:

Purpose We examined the associations between the nicotinic acetylcholine receptor polymorphism (rs1051730) on chromosome 15q25 marking the gene cluster CHRNA3-CHRNB4-CHRNA5, smoking behavior, and tobacco-related cancer and lung and cardiovascular diseases in the general population. Methods Ten thousand three hundred thirty participants from the Copenhagen City Heart Study were genotyped and observed prospectively with up to 18 years of 100% complete follow-up. Smoking behavior was measured at baseline. End points were lung cancer, bladder cancer, chronic obstructive pulmonary disease, ischemic

APA, Harvard, Vancouver, ISO, and other styles

25

Muscogiuri, Giuseppe, Marco Guglielmo, Alessandra Serra, et al. "Multimodality Imaging in Ischemic Chronic Cardiomyopathy." Journal of Imaging 8, no. 2 (2022): 35. http://dx.doi.org/10.3390/jimaging8020035.

Full text

Abstract:

Ischemic chronic cardiomyopathy (ICC) is still one of the most common cardiac diseases leading to the development of myocardial ischemia, infarction, or heart failure. The application of several imaging modalities can provide information regarding coronary anatomy, coronary artery disease, myocardial ischemia and tissue characterization. In particular, coronary computed tomography angiography (CCTA) can provide information regarding coronary plaque stenosis, its composition, and the possible evaluation of myocardial ischemia using fractional flow reserve CT or CT perfusion. Cardiac magnetic re

APA, Harvard, Vancouver, ISO, and other styles

26

Shehzadi, Shumaila, Muhammad Abul Hassan, Muhammad Rizwan, Natalia Kryvinska, and Karovič Vincent. "Diagnosis of Chronic Ischemic Heart Disease Using Machine Learning Techniques." Computational Intelligence and Neuroscience 2022 (June 14, 2022): 1–9. http://dx.doi.org/10.1155/2022/3823350.

Full text

Abstract:

Ischemic heart disease (IHD) causes discomfort or irritation in the chest. According to the World Health Organization, coronary heart disease is the major cause of mortality in Pakistan. Accurate model with the highest precision is necessary to avoid fatalities. Previously several models are tried with different attributes to enhance the detection accuracy but failed to do so. In this research study, an artificial approach to categorize the current stage of heart disease is carried out. Our model predicts a precise diagnosis of chronic diseases. The system is trained using a training dataset a

APA, Harvard, Vancouver, ISO, and other styles

27

Andonieva, N. M., O. A. Huts, M. Ya Dubovik, T. L. Valkovska, and S. M. Kolupayev. "Nephrological Aspects of Metabolic Syndrome in Patients with Chronic Kidney Disease on Peritoneal Dialysis with Different Clinical Variants of Coronary Heart Disease." Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 6, no. 6 (2021): 85–92. http://dx.doi.org/10.26693/jmbs06.06.085.

Full text

Abstract:

The purpose of the study was to identify the components of the metabolic syndrome most characteristic of different clinical variants of ischemic heart disease in patients with chronic kidney disease on peritoneal dialysis. Materials and methods. 114 patients took part in the study. The average duration of peritoneal dialysis therapy was 53 months. Clinical variants of ischemic heart disease were determined by angina attacks, by painless myocardial ischemia detected by ECG-load cycle ergometer test, by increasing phenomena of ischemic dilated cardiomyopathy (diastolic dysfunction, calcification

APA, Harvard, Vancouver, ISO, and other styles

28

Murkamilov, I., K. Aitbaev, F. Yusupov, et al. "Chronic Kidney Disease and Ischemic Heart Disease. Medical and Social Aspects." Bulletin of Science and Practice 11, no. 6 (2025): 314–33. https://doi.org/10.33619/2414-2948/115/40.

Full text

Abstract:

Chronic kidney disease (CKD) is a clinical, laboratory, and instrumental syndrome that develops against the background of the gradual and irreversible loss of nephrons. A key laboratory indicator of CKD is a decrease in the glomerular filtration rate (GFR) to ≤ 60 mL/min/1.73 m². Anemia, hyperuricemia, hyperphosphatemia, and arterial hypertension are the most common conditions accompanying CKD. In the etiological structure of CKD, the leading causes include type 2 diabetes mellitus (T2DM), hypertension, chronic heart failure (CHF), and interstitial nephropathies. Patients with CKD are classifi

APA, Harvard, Vancouver, ISO, and other styles

29

Faludi, Réka. "Chronic obstructive pulmonary disease: a cardiologist’s point of view." Orvosi Hetilap 155, no. 37 (2014): 1480–84. http://dx.doi.org/10.1556/oh.2014.29989.

Full text

Abstract:

Chronic obstructive pulmonary disease is often associated with cardiovascular diseases, such as pulmonary hypertension, ischemic heart disease, arrhythmias or heart failure. These co-morbidities may cause diagnostic or therapeutic difficulties and significantly worsen the morbidity and mortality of patients with chronic obstructive pulmonary disease. In this work the author reviews special considerations for the treatment of patients with chronic obstructive pulmonary disease who have cardiovascular co-morbidities. Orv. Hetil., 2014, 155(37), 1480–1484.

APA, Harvard, Vancouver, ISO, and other styles

30

Prikhodko, Viktoriia, and Diana Moreva. "Features of the Course and Treatment of Hypertension in Combination with Chronic Ischemic Heart Disease in Patients with Gastroesophagel Refluxdisease. Role of Proton Pump Inhibitors Test in the Diagnosis and Treatment of Different Forms of GERD." Family Medicine, no. 4 (October 5, 2016): 75–80. https://doi.org/10.30841/2307-5112.4.2016.248527.

Full text

Abstract:

The analysis of epidemiological data shows that the prevalence of GERD in Ukraine is 11.1. Prevalence of GERD increases with the age of respondents, which leads to changes in the structure of clinical disease and dominance of extraesophageal manifestations of disease. <strong>The objective: </strong>To study features of arterial hypertension (AH) combined with chronic coronary heart disease (CHD) in patients with GERD. Establish a connection presence of gastroesophageal reflux with possible clinical manifestations of coronary heart disease (arrhythmias, ischemic episodes according to the

APA, Harvard, Vancouver, ISO, and other styles

31

Canty, John M., and Gen Suzuki. "Myocardial perfusion and contraction in acute ischemia and chronic ischemic heart disease." Journal of Molecular and Cellular Cardiology 52, no. 4 (2012): 822–31. http://dx.doi.org/10.1016/j.yjmcc.2011.08.019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Restivo, L., N. Iuliano, R. Nevola, A. Amelia, M. C. Fascione, and L. E. Adinolfi. "T-02 Chronic HCV infection and extrahepatic diseases: ischemic stroke and ischemic heart disease." Digestive and Liver Disease 45 (February 2013): S13. http://dx.doi.org/10.1016/s1590-8658(13)60038-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Chiorescu, Roxana Mihaela, Mihaela Mocan, Maria Iacobescu, et al. "Behavior of Complement System Effectors in Chronic and Acute Coronary Artery Disease." Journal of Clinical Medicine 14, no. 11 (2025): 3947. https://doi.org/10.3390/jcm14113947.

Full text

Abstract:

Background/Objectives: The complement system (particularly C5b-9) is an instrumental part of the induction and progression of atherosclerosis. The fluid phase C5b-9, also known as soluble C5b-9 (sC5b-9), is a reliable indicator of terminal complement pathway activation. Response Gene to Complement (RGC)-32 is a C5b-9 effector involved in cell cycle regulation and differentiation, immunity, tumorigenesis, obesity, and vascular lesion formation. RGC-32 regulates the expression of Sirtuin1 (SIRT1), known to delay vascular aging. The aim of this study was to assess the levels of sC5b-9, RGC-32, an

APA, Harvard, Vancouver, ISO, and other styles

34

Reddy B, Sarath Kumar. "A study on the clinical profile and risk factors of ischemic heart disease in women." MedPulse International Journal of Medicine 19, no. 3 (2021): 130–32. http://dx.doi.org/10.26611/102119310.

Full text

Abstract:

Background: Ischemic heart disease (IHD) is one of the principle causes of morbidity and of mortality in women1. Ischemic heart disease may manifest clinically as either chronic stable angina or acute coronary syndrome2 (ACS). Traditional risk factors (hypertension, diabetes, etc.) contribute to the development of IHD in both women and men. Some risk factors are unique to women (e.g., pregnancy-related complications, menopause), which cause increased mortality in women Aim: To study the risk factors and clinical profile of ischemic heart disease in women. Materials And Methods: Hospital-based

APA, Harvard, Vancouver, ISO, and other styles

35

Khin, Than Yee, Kyu Maung Kyu, Win Myo, Myint Theingi, Oo Kyaw, and Myint Zaw. "Erythrocyte Antioxidant Enzymes Activities and Plasma Carbonyl Protein Levels in Smokers." Myanmar Health Sciences Research Jounral 22, no. 1 (2010): 14–18. https://doi.org/10.5281/zenodo.3373348.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Azimboyevich, Nurullayev Baxtiyor, and Rustam Turakulov Ismatullaevich. "Evaluation of glomerular filtration rate estimated by cystatin c in chronic obstructive pulmonary disease comorbid with ischemic heart disease." International Journal of Medical Science and Public Health Research 6, no. 7 (2025): 14–20. https://doi.org/10.37547/ijmsphr/volume06issue07-03.

Full text

Abstract:

Background: Chronic obstructive pulmonary disease (COPD) and ischemic heart disease (IHD) frequently coexist, contributing to systemic inflammation and potential renal dysfunction. Cystatin C, a novel biomarker, may provide a more accurate assessment of glomerular filtration rate (GFR) in these patients compared to traditional creatinine-based methods. Objective: To evaluate GFR using cystatin C in patients with COPD and comorbid IHD and compare it with creatinine-based estimations. Methods: A cross-sectional study was conducted involving 120 patients diagnosed with COPD and IHD. Serum cystati

APA, Harvard, Vancouver, ISO, and other styles

37

Antani, J. A., Nirmal J. Antani, and A. S. Nanivadekar. "Prazosin in Chronic Congestive Heart Failure Due to Ischemic Heart Disease." Clinical Cardiology 14, no. 6 (1991): 495–500. http://dx.doi.org/10.1002/clc.4960140608.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Nedevska, M., V. Grudeva, and A. Partenova. "Cardiac magnetic resonance imaging in acute and chronic myocardial ischemia: current clinical application and future directions." Bulgarian Cardiology 28, no. (4) (2022): 29–42. https://doi.org/10.3897/bgcardio.28.e97466.

Full text

Abstract:

Ischemic heart disease, its sequelae and complications contribute substantially to morbidity and mortality worldwide. Significant technological progress in recent years has significantly expanded the application of non-invasive imaging modalities in the systematic and complex evaluation of patients with ischemic heart disease in the preclinical and clinically developed stages of the disease. Cardiac magnetic resonance imaging includes a complex morphological and functional assessment. Regional and global myocardial kinetics and function, morphological changes in myocardial tissue in the form o

APA, Harvard, Vancouver, ISO, and other styles

39

Ostroumova, O. D., I. A. Alautdinova, A. I. Kochetkov, and S. N. Litvinova. "Felodipine in Treatment of Arterial Hypertension and Ischemic Heart Disease." Rational Pharmacotherapy in Cardiology 16, no. 4 (2020): 654–62. http://dx.doi.org/10.20996/1819-6446-2020-08-13.

Full text

Abstract:

Cardiovascular diseases are the leading cause of death both in the world and in the Russian Federation. The most significant contributors to the increase in mortality are arterial hypertension (AH) and ischemic heart disease (IHD). Dihydropyridine calcium channel blockers (CCBs) are the first line of treatment for these conditions. This is noted in the clinical guidelines for the diagnosis and treatment of AH and in the guidelines for the management of patients with chronic coronary syndromes. CCBs are a heterogeneous group of drugs that have both general and individual pharmacokinetic and pha

APA, Harvard, Vancouver, ISO, and other styles

40

Tanaka, Yuri, Nobuhiko Joki, and Hiroki Hase. "Ischemic Heart Disease in Patients with End-Stage Kidney Disease." Blood Purification 40, no. 4 (2015): 332–36. http://dx.doi.org/10.1159/000441582.

Full text

Abstract:

Background: It was recently reported that the severity of coronary and carotid atherosclerosis in patients with end-stage kidney disease (ESKD) has improved over the last two decades. However, the frequency of coronary artery events observed at the initiation of dialysis remains high. Summary: Recently, 5 different clinical types of acute myocardial infarction (MI) were introduced in the third universal definition of MI. Type 2 MI, known as secondary MI, is a more heterogeneous entity, where a condition other than coronary artery narrowing contributes to an acute imbalance in oxygen supply and

APA, Harvard, Vancouver, ISO, and other styles

41

Nobre, Moacyr Roberto Cuce, and Rachel Zanetta de Lima Domingues. "Patient adherence to ischemic heart disease treatment." Revista da Associação Médica Brasileira 63, no. 3 (2017): 252–60. http://dx.doi.org/10.1590/1806-9282.63.03.252.

Full text

Abstract:

Summary Introduction: The effectiveness of the treatment of chronic diseases depends on the participation of the patient, influenced by different sociocultural factors, which are not fully recognized by the treatment routine. Objective: To search for some of these factors that hinder or facilitate adherence to treatment and use of healthcare resources, approaching patients with ischemic heart disease. Method: A cross-sectional study was conducted using face-to-face interviews. We applied semi-structured questionnaires to 347 individuals and recorded 141 interviews for qualitative analysis. Des

APA, Harvard, Vancouver, ISO, and other styles

42

Eremin, Andrey V., A. V. Lepilin, T. E. Lipatova, and I. M. Kvetnoy. "Chronic periodontitis and ischemic heart disease: morphofunctional relation-ships." Russian Journal of Dentistry 24, no. 4 (2020): 219–24. http://dx.doi.org/10.17816/1728-2802-2020-24-4-219-224.

Full text

Abstract:

The relationship between periodontal diseases and cardiovascular pathology is actively being studied. The clinical significance of tissue markers of endothelial dysfunction in acute or chronic periodontitis needs to be clarified. Materials and methods. The results of the examination of 65 patients with chronic generalized periodontitis (CP), 35 patients with chronic coronary heart disease (CHD), and 35 patients with combined pathology including CHD and CP were presented. Clinical instrumental examination, assessment of the functional state of the endothelium, immunohistochemical, and mor

APA, Harvard, Vancouver, ISO, and other styles

43

Shimizu, Hideki, Keiko Sai, Takanori Kumagai, et al. "Diagnosis of ischemic heart disease in chronic dialysis patients." Nihon Toseki Igakkai Zasshi 38, no. 9 (2005): 1571–74. http://dx.doi.org/10.4009/jsdt.38.1571.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Lebedeva, E. V., E. D. Schastny, G. G. Simutkin, T. G. Nonka, S. N. Vasil'eva, and A. N. Repin. "ATYPICAL DEPRESSION IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE." Bulletin of Medical Science, no. 2 (2021): 47–58. http://dx.doi.org/10.31684/25418475_2021_2_47.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Abdel-Latif, Ahmed, Paula M. Heron, Andrew J. Morris, and Susan S. Smyth. "Lysophospholipids in coronary artery and chronic ischemic heart disease." Current Opinion in Lipidology 26, no. 5 (2015): 432–37. http://dx.doi.org/10.1097/mol.0000000000000226.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Rostand, Stephen G., and Edwin A. Rutsky. "Ischemic Heart Disease in Chronic Renal Failure: Management Considerations." Seminars in Dialysis 2, no. 2 (2007): 98–101. http://dx.doi.org/10.1111/j.1525-139x.1989.tb00566.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Marzilli, Mario, Silvia Affinito, and Marta Focardi. "Changing Scenario in Chronic Ischemic Heart Disease: Therapeutic Implications." American Journal of Cardiology 98, no. 5 (2006): 3–7. http://dx.doi.org/10.1016/j.amjcard.2006.07.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Khuzhamberdiev, M. "Activation of lipid peroxidation in chronic ischemic heart disease." Bulletin of Experimental Biology and Medicine 100, no. 3 (1985): 1179–81. http://dx.doi.org/10.1007/bf00839403.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Todorova, Marieta. "THE INFLUENCE OF CHRONIC ISCHEMIC HEART DISEASE ON THE SOCIAL LIFE OF PATIENTS." Knowledge International Journal 32, no. 2 (2019): 267–70. http://dx.doi.org/10.35120/kij3202267t.

Full text

Abstract:

Chronic diseases, including chronic ischemic heart disease, have an impact on patients' daily life and social lives. On the other hand, behavioral and psychological risk factors, poor social adaptation are predictors of disease progression or acute coronary syndrome. The aim of the study is to analyze the impact of chronic ischemic heart disease on patients' social lives.Methods: 146 patients with chronic ischemic heart disease and a control group of 146 subjects were interviewed. The two groups are equal by gender. A survey questionnaire containing questions about the demographic characterist

APA, Harvard, Vancouver, ISO, and other styles

50

Gautam, Mani Prasad, Surakshya Bhattarai, Sanjog Kandel, Rajesh Panjiyar, and Bishal Shrestha. "Spectrum of Cardiovascular Diseases in the Cardiology Unit of Bharatpur Hospital." Journal of National Heart and Lung Society Nepal 3, no. 2 (2024): 69–75. https://doi.org/10.3126/jnhls.v3i2.72666.

Full text

Abstract:

Background: Cardiovascular diseases (CVDs) are a leading cause of morbidity and mortality worldwide and its burden is on rise. CVDs encompass a range of disorders, including ischemic heart disease, valvular heart diseases, heart failure, arrhythmias, and hypertensive heart disease. Understanding the patterns of CVDs in our setting, where advanced interventional care is unavailable, can inform strategies for improving patient care, optimizing resources, and guiding healthcare policy. The study aimed to evaluate the spectrum of cardiovascular diseases (CVDs) in the cardiology unit of Bharatpur H

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!